#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15292	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2049	741.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	908	C,G	803,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28000	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3500	797.7	0	.	n	.	0	T695C	SNP	695	695	T	994	994	C	843	C	745	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28000	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3500	797.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	1937	1937	G	944	G,A	665,195	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28000	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3500	797.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2270	2270	C	920	C	831	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28000	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3500	797.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2344	2344	A	876	A	790	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28000	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3500	797.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2896	2896	C	932	C,G	854,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2306	folP	855	855	100.0	folP.l15.c30.ctg.1	1597	143.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1061	1063	AGC	223;221;221	A;G;C	203;204;204	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5518	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3440	159.9	1	SNP	p	S91F	1	.	.	271	273	TTC	564	566	TTC	186;185;184	T;T;C	167;164;162	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5518	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3440	159.9	1	SNP	p	D95G	1	.	.	283	285	GGC	576	578	GGC	192;194;194	G;G;C	169;169;169	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5518	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3440	159.9	1	SNP	p	G95N	0	.	.	283	285	GGC	576	578	GGC	192;194;194	G;G;C	169;169;169	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1666	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1404	118.1	1	SNP	p	G45D	0	.	.	133	135	GGC	404	406	GGC	221;222;221	G;G;C,T	195;198;195,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	820	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1015	80.6	0	.	n	.	0	A197.	DEL	197	197	A	599	599	A	216	A	197	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5814	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2863	202.1	1	SNP	p	D86N	0	.	.	256	258	GAC	532	534	GAC	257;256;256	G;A,C;C	230;224,1;228	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5814	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2863	202.1	1	SNP	p	R87W	0	.	.	259	261	CGT	535	537	CGT	256;254;257	C;G,A;T	227;226,1;228	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5814	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2863	202.1	1	SNP	p	S87R	1	.	.	259	261	CGT	535	537	CGT	256;254;257	C;G,A;T	227;226,1;228	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5814	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2863	202.1	1	SNP	p	R87I	0	.	.	259	261	CGT	535	537	CGT	256;254;257	C;G,A;T	227;226,1;228	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5814	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2863	202.1	1	SNP	p	S88P	0	.	.	262	264	TCC	538	540	TCC	255;257;253	T,C;C;C	229,1;231;227	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5048	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2750	183.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1632	1634	GGC	236;231;231	G;G;C	208;203;202	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4362	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2217	195.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1121	1123	GCC	248;250;248	G;C;C	220;220;219	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4362	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2217	195.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1124	1126	ATG	248;251;252	A;T,C;G	220;219,1;222	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4362	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2217	195.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1136	1138	ACC	252;251;250	A;C;C	216;218;217	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4362	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2217	195.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1136	1138	ACC	252;251;250	A;C;C	216;218;217	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4362	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2217	195.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1637	1639	ACC	250;253;251	A;C;C	214;223;225	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4362	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2217	195.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1691	1693	GCG	241;241;244	G;C;G	213;212;217	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4362	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2217	195.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1691	1693	GCG	241;241;244	G;C;G	213;212;217	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4362	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2217	195.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1814	1816	GGT	230;230;234	G;G;T	204;203;201	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4362	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2217	195.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1823	1825	AGC	220;221;221	A;G;C	191;189;191	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4362	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2217	195.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1841	1843	CCG	176;180;181	C,G;C,G;G	135,5;144,1;142	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6046	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3027	199.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1612	1614	CCG	219;220;219	C;C;G	193;198;190	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2518	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1697	147.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	483	483	C	193	C	171	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2998	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1606	185.5	0	.	p	.	0	I45V	NONSYN	133	135	ATT	443	445	GTT	259;257;256	G,A;T;T	241,1;239;240	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2998	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1606	185.5	1	SNP	p	G120K	1	.	.	358	360	AAG	668	670	AAG	266;266;262	A;A;G	241;238;235	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2998	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1606	185.5	1	SNP	p	A121N	1	.	.	361	363	AAC	671	673	AAC	264;263;261	A;A;C	240;239;235	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2998	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1606	185.5	1	SNP	p	N121D	0	.	.	361	363	AAC	671	673	AAC	264;263;261	A;A;C	240;239;235	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11020	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4958	221.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1142	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1146	99.5	1	SNP	p	V57M	1	.	.	169	171	ATG	570	572	ATG	230;231;229	A;T;G	216;214;215	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
